Skip to main content
    A

    Aprea Therapeutics Inc (APRE)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.45
    +0.05 (+11.52%)

    Market Cap: $5.91M

    Last updated: Nov 17, 2026 at 4:17 PM ET

    Aprea Therapeutics Inc (APRE) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Aprea Therapeutics (APRE) has a latest price of $0.45 on Nov 17, 2026, 64.8% below its 52-week high of $1.29. Its price fell 62.6% over the past 12 months. The month-end price fell 99.5% over the 5 years through Oct 2026, a compound annual decline of 65.5%.

    Price Chart

    From Oct 2019 to Oct 2026, its highest month-end close was $917.80 in Dec 2019 and its lowest $0.48 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart APRE with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for APRE.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 32.5%, and over 6 months it fell 43.4%. The month-end price fell 85.6% over the 3 years through Oct 2026, a compound annual decline of 47.6%.

    PeriodChange
    1 month-14.9%
    3 months-32.5%
    6 months-43.4%
    12 months-62.6%
    12 months, with dividends-62.6%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-85.6%-47.6%
    5 years-99.5%-65.5%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2023, when the price fell 29.0%, and its weakest was 2020, when it fell 89.3%.

    YearCloseChange
    2026 through Oct 2026$0.48-43.2%
    2025$0.85-74.1%
    2024$3.29-30.0%
    2023$4.70-29.0%
    2022$6.62-88.5%
    2021$57.40-41.7%
    2020$98.40-89.3%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 25.7% below its 50-day average of $0.61 and 38.2% below its 200-day average of $0.73.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.45
    52-week high$1.29-64.8%
    52-week low$0.40+13.3%
    50-day average$0.61-25.7%
    200-day average$0.73-38.2%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 95.2%.

    MeasureValue
    1-year beta0.68
    Largest fall, 1 year-67.8%
    Largest fall, 3 years-95.2%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About APRE

    What is APRE's 1-year price change?

    Aprea Therapeutics's price fell 62.6% over the past 12 months. With dividends included, the 12-month total return was -62.6%.

    What is APRE's 5-year price change?

    Aprea Therapeutics's month-end price fell 99.5% over the 5 years through Oct 2026, a compound annual decline of 65.5%. These figures leave out dividends.

    What is APRE's 52-week high and low?

    Aprea Therapeutics's 52-week high is $1.29 and its 52-week low is $0.40. Its latest price of $0.45 on Nov 17, 2026 is 64.8% below the high.

    What is APRE's beta?

    Aprea Therapeutics's 1-year beta against the S&P 500 is 0.68, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 67.8%.

    Is the APRE chart free?

    Yes. Advanced Charting for APRE is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.